CANCER CONTROL A011502

Study #A011502

HER2: A Randomized Phase III Double Blinded Placebo Controlled Trial of Aspirin as Adjuvant Therapy for Node Positive HER2 Negative Breast Cancer: The ABC Trial

Back To Clinical Trials